57 results
CORRESP
INBS
Intelligent Bio Solutions Inc
30 Sep 22
Correspondence with SEC
12:00am
not include a report of management’s assessment regarding internal control over financial reporting due to a transition period established … management’s assessment of internal control and revise your Exhibit 31 certifications accordingly. We refer you to Item 308 of Regulation S-K.
Response
UPLOAD
INBS
Intelligent Bio Solutions Inc
22 Sep 22
Letter from SEC
12:00am
of management s
assessment regarding internal control over financial reporting due to a
transition …
s assessment of internal control and revise your Exhibit
31 certifications
accordingly. We
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
30 Jun 23
Regulation FD Disclosure
4:30pm
. The preliminary assessment, in response to the Company’s March 2023 513(g) request for product classification, provides a clear regulatory pathway for INBS … Intelligent Fingerprinting Drug Screening Cartridge.
“We are pleased to receive the FDA’s preliminary assessment for our Intelligent Fingerprinting
8-K
EX-99.1
INBS
Intelligent Bio Solutions Inc
16 Dec 21
GBS Inc. Announces Application for FDA Breakthrough Device Designation to Fast Track Rapid Saliva Glucose Test
4:05pm
to these medical devices by speeding up their development, assessment, and review.
About GBS Inc.
GBS Inc. is a life sciences company developing non
S-1/A
EX-10.2
ud7yk3u3h2
2 Aug 19
IPO registration (amended)
4:38pm
8-K/A
EX-99.2
l2bujkff
8 Dec 22
Financial Statements and Exhibits
4:41pm
8-K
EX-2.1
bauldoghso154bbqa5q
11 Oct 22
GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology
6:07am